Phase 2 data

CStone CS2009 Shows Strong Phase I/II Cancer Data

Suzhou, China – March 26, 2026 CStone Pharmaceuticals announced significant clinical progress for its trispecific antibody CS2009, highlighting strong...

By cGxPwire Editor
March 27, 2026

Bio-Pharma

Rivus Pharmaceuticals Reports Positive Phase 2 Results for HU6 in MASH Patients

CHARLOTTESVILLE, Va., and SOUTH SAN FRANCISCO, Calif., November 7, 2025 — Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company pioneering...